Papillary Thyroid Carcinoma Clinical Trials
3 recruiting trials for Papillary Thyroid Carcinoma. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Papillary Thyroid Carcinoma clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Ming-an Yu (1), Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1), Beijing Friendship Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Humanistic Continuing Care via WeChat (behavioral, 1 trial), followed by Usual Care (No Structured WeChat Program), single-incision, gasless endoscopic total thyroidectomy with central compartment neck dissection.
Track Papillary Thyroid Carcinoma trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
The goal of this clinical trial is to test whether human-centered nursing care lowers emotional distress and improves quality of life for people who are awake during thyroid...
Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC
Historically, performing a contralateral thyroid lobectomy and lymph node dissection via the subclavian approach was considered challenging. This study aimed to evaluate the...
A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma
A prospective cohort of papillary thyroid carcinoma(PTC), patients who received thermal ablation in our hospital since February 2023 was established as the study object....
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Papillary Thyroid Carcinoma, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Papillary Thyroid Carcinoma, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Papillary Thyroid Carcinoma, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.